AeroLeads people directory · profile
Daniel Geffken Email & Phone Number
Founder and Managing Director
at
Danforth Advisors
LinkedIn matched
✓ Verified Jun 2026
3 data sources
Profile completeness 86%
Current company
Role
Founder and Managing Director
Location
Cambridge, Massachusetts, United States
Who is Daniel Geffken? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Daniel Geffken is listed as Founder and Managing Director at Danforth Advisors, based in Cambridge, Massachusetts, United States. AeroLeads shows a matched LinkedIn profile for Daniel Geffken.
Daniel Geffken previously worked as Interim Chief Financial Officer at Eloxx Pharmaceuticals and Senior Financial Advisor at Olaris, Inc. Daniel Geffken holds Mba from Harvard Business School.
Company email context
Email format at Danforth Advisors
This section adds company-level context without repeating Daniel Geffken's masked contact details.
Danforth Advisors
Review company-level records connected to Daniel Geffken before choosing the right outreach path.
Profile bio
About Daniel Geffken
Daniel Geffken is a Founder and Managing Director at Danforth Advisors.
Current workplace
Daniel Geffken's current company
Company context helps verify the profile and gives searchers a useful next step.
79 roles · 47 years
Daniel Geffken work experience
A career timeline built from the work history available for this profile.
Founder And Managing Director
CurrentDanforth Advisors partners with life science companies to help them start, grow and successfully operate towards their best possible outcomes. We advise and execute in the areas of finance, accounting and operations, providing specialized services that are informed by industry perspective and carried out by consultants who are experienced in this uniquely.
Aug 2011 - Present
Interim Chief Financial Officer
Current
Apr 2021 - Present
Senior Financial Advisor
Current
Mar 2021 - Present
Chief Financial Officer
Current
Locust Walk Acquisition Corp.
Dec 2020 - Present
Senior Financial Advisor
Current
Affini-T
Feb 2021 - Present
Senior Financial Advisor
Current
Feb 2021 - Present
Senior Financial Advisor
Current
Jan 2021 - Present
Interim Chief Financial Officer
Current
Nov 2020 - Present
Interim Chief Financial Officer
Current
Dermbiont Therapeutics
Oct 2020 - Present
Senior Financial Advisor
Current
Jan 2020 - Present
Senior Financial Advisor
Current
Mar 2020 - Present
Senior Financial Advisor
Current
Nia Therapeutics
Mar 2018 - Present
Interim Chief Financial Officer
Current
Apic Bio, Inc.
Mar 2018 - Present
Interim Chief Financial Officer
Current
Antolrx, Inc.
Jun 2016 - Present
Interim Chief Financial Officer And Director
Current
Apr 2014 - Present
Chief Financial Officer
Current
Nov 2016 - Present
Senior Financial Advisor
Current
Palvella Therapeutics
Aug 2020 - Present
Interim Chief Financial Officer
May 2021 - Sep 2022
Senior Financial Advisor
Mar 2021 - Aug 2022
Interim Chief Financial Officer
Vigeo Therapeutics
Nov 2017 - Mar 2022
Interim Chief Financial Officer
Zikani Therapeutics
Jul 2019 - Mar 2021
Interim Chief Financial Officer
Mar 2020 - Jan 2021
Senior Financial Advisor
Graybug Vision, Inc.
Sep 2019 - Oct 2020
Interim Chief Financial Officer
Atea Pharmaceuticals
Jul 2019 - Sep 2020
Interim Chief Financial Officer
Lysosomal Technologies, Inc.
Jul 2013 - Jul 2020
Interim Chief Financial Officer
Promedior, Inc
May 2012 - Mar 2020
Senior Financial Advisor
Apr 2018 - Dec 2019
Interim Chief Financial Officer
Aquinnah Pharmaceuticals
Dec 2017 - Dec 2019
Senior Financial Advisor
Kallyope, Inc.
Kalllyope announced in December 2015 a $40M Series A. Congratulations.
Sep 2015 - Dec 2019
Interim Chief Financial Officer
Nov 2016 - May 2019
Senior Financial Advisor
Nov 2015 - Apr 2019
Senior Financial Advisor
Immunsant
Oct 2018 - Mar 2019
Senior Financial Advisor
Oct 2015 - Feb 2019
Interim Chief Financial Officer
Recover Together (Dba, Groups, Inc.)
Aug 2017 - Sep 2018
Senior Financial Advisor
Pear Therapeutics
Apr 2016 - Sep 2018
Interim Chief Financial Officer
Entrada Therapeutics, Inc.
Sep 2016 - Aug 2018
Member Board Of Directors
Vyriad, Inc.
Leader in the development of oncolytic viruses.
Sep 2016 - Jul 2018
Interim Chief Financial Officer
Genepeeks, Inc.
Aug 2015 - Jun 2018
Senior Financial Advisor
Oct 2014 - Jun 2018
Board Of Directors
Arcturus Therapeutics
Nov 2017 - May 2018
Interim Chief Financial Officer
Opsonix, Inc.
Jul 2015 - May 2018
Interim Chief Financial Officer
Opsonix, Inc.
Jun 2015 - May 2018
Senior Financial Advisor
Elucida Oncology, Inc.
Nov 2017 - Jan 2018
Interim Chief Financial Officer
Aug 2015 - Oct 2017
Board Of Directors; Audit Committee, Compensation Committee
Alcobra Ltd
Alcobra Ltd., founded in 2008 and headquartered in Tel Aviv, Israel, is an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome. Metadoxine Extended Release (MDX) is the company’s lead investigational product.
May 2013 - Oct 2017
Senior Financial Advisor
Wntrx Pharmaceuticals
Nov 2016 - Jun 2017
Senior Financial Advisor
Jan 2013 - Jun 2017
Interim Chief Financial Officer
Homology Medicines, Inc.
May 2015 - Mar 2017
Senior Financial Advisor
Aug 2015 - Dec 2016
Senior Finanical Advisor
Apr 2016 - Oct 2016
Senior Financial Advisor
Chiasma, Inc.
Jan 2015 - Jun 2016
Interim Chief Financial Officer
Provide interim financial services to publicly traded mRNA company.
Jan 2014 - Jun 2016
Senior Financial Advisor
Alcresta, Inc.
Oct 2014 - Dec 2015
Interim Chief Financial Officer
X4 Therapeutics
Mar 2015 - Nov 2015
Interim Chief Financial Officer
Aug 2013 - Nov 2015
Senior Financial Advisor
Mar 2015 - Oct 2015
Senior Financial Advisor
Sep 2014 - Aug 2015
Interim Chief Financial Officer
Sep 2013 - Jul 2015
Senior Financial Advisor
H3 Biomedicine
Feb 2015 - Jun 2015
Senior Financial Advisor
Anchor Therapeutics
Through Danforth Advisors, we provide operational and financial consulting services.
Mar 2012 - Mar 2015
Chief Financial Officer
Sideris Pharmaceuticals
Dec 2012 - Jan 2015
Senior Financial Consultant
Genocea Biosciences
Jun 2012 - Sep 2014
Interim Chief Financial Officer
Novira Therapeutics
Aug 2012 - Jun 2014
Senior Financial Consultant
Developed strategic financial plan for prestige brand beauty products company, founded on MIT technology.
Aug 2013 - Dec 2013
Interim Chief Financial Officer
Usds, Inc.
Jul 2011 - Sep 2013
Interim Cfo
Bionostics, Inc
Jun 2012 - Aug 2013
Strategic Advisor
Acusphere
Through Danforth Advisors, I provide financial strategy consulting and fundraising assistance.
Feb 2012 - Jun 2013
Strategic Advisor
Infobionic, Inc.
Feb 2012 - Dec 2012
Senior Advisor, Finance And Operations
Through Danforth Advisors, I lead senior advisory services in the areas of finance, operations and human resources. Algeta is a publicly-traded Norwegian biotechnology company that is establishing a US sale subsidiary.
Mar 2012 - Nov 2012
Chief Operating Officer
Seaside Therapeutics is creating new drug treatments to correct or improve the course of Fragile X Syndrome, autism and other disorders of brain development. We are dedicated to translating breakthrough discoveries in neurobiology into therapeutics that improve the lives of patients and their families.
Aug 2009 - Feb 2011
Principal
Daniel Geffken Consulting, Llc
Daniel Geffken Consulting provides financial leadership and strategy consulting to companies in the life sciences and renewable energy industries.
2008 - Aug 2009
Chief Financial Officer
Codon Devices
2006 - 2008
~2 yrs
Evp, Chief Financial Officer
2006 - 2007
~1 yr
Svp, Chief Financial Officer
2003 - 2006
~3 yrs
Svp, Chief Financial Officer
Jan 1997 - Apr 2003
Vp, Chief Financial Officer
Cytotherpeutics, Inc.
1993 - 1997
~4 yrs
Chief Financial Officer
Medchem Products
1989 - 1991
~2 yrs
Senior Audit Manager
1979 - 1985
~6 yrs
2 education records
Daniel Geffken education
Mba
Harvard Business School
B.S. In Economics, Economics
The Wharton School
FAQ
Frequently asked questions about Daniel Geffken
Quick answers generated from the profile data available on this page.
What company does Daniel Geffken work for?
Daniel Geffken works for Danforth Advisors.
What is Daniel Geffken's role at Danforth Advisors?
Daniel Geffken is listed as Founder and Managing Director at Danforth Advisors.
Where is Daniel Geffken based?
Daniel Geffken is based in Cambridge, Massachusetts, United States while working with Danforth Advisors.
What companies has Daniel Geffken worked for?
Daniel Geffken has worked for Danforth Advisors, Eloxx Pharmaceuticals, Olaris, Inc, Locust Walk Acquisition Corp., and Affini-T.
How can I contact Daniel Geffken?
You can use AeroLeads to view verified contact signals for Daniel Geffken at Danforth Advisors, including work email, phone, and LinkedIn data when available.
What schools did Daniel Geffken attend?
Daniel Geffken holds Mba from Harvard Business School.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial